Notify me when YK Bioventures Opportunities GP I, LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CERO | CERO THERAPEUTICS HOLDINGS, INC. | Common stock, par value $0.0001 per share | 0% | $680 | 17,002 | YK Bioventures Opportunities GP I, LLC | 13 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|